44 peptides · regulatory reference · not medical advice
Peptide FDA Status Tracker
See which peptides are FDA-approved, compoundable, or research-only — plus 503A compounding bans, whether a prescription is required, and telehealth availability. Search, filter by status, and sort any column.
9
FDA Approved
4
Compoundable
21
Research Only
22
Banned from Compounding
| 503A Ban | Rx Required | Telehealth | |||
|---|---|---|---|---|---|
Adipotide | Fat loss | Research Only | 503A ban | — | — |
Afamelanotide (Melanotan I) Scenesse — erythropoietic protoporphyria. | Skin | FDA Approved | — | — | |
AOD-9604 | Fat loss | Research Only | 503A ban | — | — |
BPC-157 FDA category 2 — not eligible for compounding. | Healing / recovery | Research Only | 503A ban | — | — |
Cagrilintide | Amylin analog | Investigational | — | — | |
Cerebrolysin | Nootropic | Intl. Approved | — | — | — |
CJC-1295 | GH secretagogue | Research Only | 503A ban | — | |
CJC-1295 (No-DAC) | GH secretagogue | Research Only | 503A ban | — | |
Dihexa | Nootropic | Research Only | 503A ban | — | — |
DSIP | Sleep | Research Only | 503A ban | — | — |
Elamipretide (SS-31) Phase 3 trials. | Mitochondrial | Investigational | — | — | |
Epithalon | Longevity | Research Only | 503A ban | — | — |
Follistatin | Muscle | Research Only | — | — | — |
GHK-Cu OTC in topical skincare; injectable is research-only. | Cosmetic / skin | OTC Cosmetic | 503A ban | — | |
GHRP-2 | GH secretagogue | Research Only | 503A ban | — | — |
GHRP-6 | GH secretagogue | Research Only | 503A ban | — | — |
Glutathione | Antioxidant | Compoundable | — | ||
Gonadorelin | Fertility | Compoundable | — | ||
Hexarelin | GH secretagogue | Research Only | 503A ban | — | — |
HGH Fragment 176-191 | Fat loss | Research Only | 503A ban | — | — |
IGF-1 LR3 | Growth factor | Research Only | — | — | — |
Ipamorelin | GH secretagogue | Research Only | 503A ban | — | |
Kisspeptin | Fertility / hormone | Research Only | 503A ban | — | — |
KPV | Anti-inflammatory | Research Only | 503A ban | — | — |
Liraglutide | GLP-1 | FDA Approved | — | ||
LL-37 | Immune / antimicrobial | Research Only | — | — | — |
Melanotan II | Tanning | Not Approved — Caution | 503A ban | — | — |
MOTS-c | Mitochondrial / longevity | Research Only | 503A ban | — | — |
NAD+ Compounded IV/injectable. | Longevity | Compoundable | — | ||
Oxytocin | Hormone | FDA Approved | — | ||
Pentosan Polysulfate Elmiron — interstitial cystitis. | Joint / bladder | FDA Approved | — | — | |
PT-141 (Bremelanotide) Vyleesi — HSDD. | Sexual health | FDA Approved | — | ||
Retatrutide Phase 3 trials. | GLP-1 / GIP / GCG | Investigational | — | — | |
Selank Approved in Russia. | Nootropic / anxiety | Intl. Approved | 503A ban | — | — |
Semaglutide Ozempic / Wegovy / Rybelsus. | GLP-1 | FDA Approved | — | ||
Semax Approved in Russia. | Nootropic | Intl. Approved | 503A ban | — | — |
Sermorelin Formerly approved (Geref); now commonly compounded. | GH secretagogue | Compoundable | — | ||
Survodutide | GLP-1 / GCG | Investigational | — | — | |
TB-500 (Thymosin β4) | Healing / recovery | Research Only | 503A ban | — | — |
Tesamorelin Egrifta — HIV lipodystrophy. | GH secretagogue | FDA Approved | — | ||
Thymosin Alpha-1 Zadaxin — approved in many countries, not the US. | Immune | Intl. Approved | 503A ban | — | — |
Thymulin | Immune | Research Only | — | — | — |
Tirzepatide Mounjaro / Zepbound. | GLP-1 / GIP | FDA Approved | — | ||
Vasopressin Vasostrict. | Hormone | FDA Approved | — | — |
Showing 44 of 44 peptides.
What the statuses mean
- FDA Approved
- — Approved by the FDA for a specific indication; available by prescription.
- Compoundable
- — Not a standalone approved drug, but legally prepared by compounding pharmacies with an Rx.
- Research Only
- — Sold 'for research use only' — not approved for human use.
- OTC Cosmetic
- — Permitted in topical over-the-counter cosmetics (not for injection).
- Investigational
- — In active clinical trials (e.g. Phase 2 / Phase 3); not yet approved.
- Intl. Approved
- — Approved in some countries outside the US, but not by the FDA.
- Not Approved — Caution
- — Not approved and associated with notable safety concerns.
- 503A Ban
- — Flagged by the FDA as not eligible for 503A pharmacy compounding.
Regulatory reference only
This tracker is for educational reference and is not legal or medical advice. Regulatory status changes over time. Always verify current status directly with the FDA and consult a licensed healthcare professional before making any decision.